BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 23543581)

  • 1. Anti-D administration after spontaneous miscarriage for preventing Rhesus alloimmunisation.
    Karanth L; Jaafar SH; Kanagasabai S; Nair NS; Barua A
    Cochrane Database Syst Rev; 2013 Mar; (3):CD009617. PubMed ID: 23543581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-D administration in pregnancy for preventing Rhesus alloimmunisation.
    McBain RD; Crowther CA; Middleton P
    Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD000020. PubMed ID: 26334436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-D administration in pregnancy for preventing Rhesus alloimmunisation.
    Crowther CA; Middleton P; McBain RD
    Cochrane Database Syst Rev; 2013 Feb; (2):CD000020. PubMed ID: 23450526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intramuscular versus intravenous anti-D for preventing Rhesus alloimmunization during pregnancy.
    Okwundu CI; Afolabi BB
    Cochrane Database Syst Rev; 2013 Jan; (1):CD007885. PubMed ID: 23440818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of Rh alloimmunization.
    Fung Kee Fung K; Eason E; Crane J; Armson A; De La Ronde S; Farine D; Keenan-Lindsay L; Leduc L; Reid GJ; Aerde JV; Wilson RD; Davies G; Désilets VA; Summers A; Wyatt P; Young DC;
    J Obstet Gynaecol Can; 2003 Sep; 25(9):765-73. PubMed ID: 12970812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-D administration in pregnancy for preventing rhesus alloimmunisation.
    Crowther CA; Keirse MJ
    Cochrane Database Syst Rev; 2000; (2):CD000020. PubMed ID: 10796088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The scientific basis of antenatal prophylaxis.
    Urbaniak SJ
    Br J Obstet Gynaecol; 1998 Nov; 105 Suppl 18():11-8. PubMed ID: 9863973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-D administration after childbirth for preventing Rhesus alloimmunisation.
    Crowther C; Middleton P
    Cochrane Database Syst Rev; 2000; 1997(2):CD000021. PubMed ID: 10796089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do Rh-negative women with first trimester spontaneous abortions need Rh immune globulin?
    Hannafin B; Lovecchio F; Blackburn P
    Am J Emerg Med; 2006 Jul; 24(4):487-9. PubMed ID: 16787810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rhesus isoimmunisation in unsensitised RhD-negative individuals seeking abortion at less than 12 weeks' gestation: a systematic review.
    Chan MC; Gill RK; Kim CR
    BMJ Sex Reprod Health; 2022 Jul; 48(3):163-168. PubMed ID: 34819315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prevention of Rh (D) alloimmunization in Rh (D) negative women in pregnancy and after birth of Rh (D) positive infant].
    L'ubuský M; Procházka M; Krejcová L; Vetr M; Santavý J; Kudela M
    Ceska Gynekol; 2006 May; 71(3):173-9. PubMed ID: 16768042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple micronutrient powders for home (point-of-use) fortification of foods in pregnant women.
    Suchdev PS; Peña-Rosas JP; De-Regil LM
    Cochrane Database Syst Rev; 2015 Jun; 2015(6):CD011158. PubMed ID: 26091836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of anti-D prophylaxis in the management of miscarriage in general practice.
    Roberts H; Mitchell R
    Health Bull (Edinb); 1991 Jul; 49(4):245-9. PubMed ID: 1657828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of maternal alloimmunisation to Rh D in Northern Ireland.
    McCauley CJ; Morris K; Maguire K
    Transfus Med; 2017 Apr; 27(2):132-135. PubMed ID: 28101958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of maternal fetal red blood cell count in rhesus-positive pregnant women.
    Lebrun B; Jacquemyn Y
    Horm Mol Biol Clin Investig; 2018 Jul; 35(3):. PubMed ID: 30059348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical validation of routine antenatal anti-D prophylaxis questions the modelling predictions adopted by NICE for Rhesus D sensitisation rates: results of a longitudinal study.
    Mackenzie IZ; Roseman F; Findlay J; Thompson K; McPherson K
    Eur J Obstet Gynecol Reprod Biol; 2008 Jul; 139(1):38-42. PubMed ID: 18243487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ante-partum administration of preventive treatment of Rh-D immunization in rhesus-negative women. Parallel evaluation of transplacental passage of fetal blood cells. Results of a multicenter study carried out in the Paris region].
    Huchet J; Dallemagne S; Huchet C; Brossard Y; Larsen M; Parnet-Mathieu F
    J Gynecol Obstet Biol Reprod (Paris); 1987; 16(1):101-11. PubMed ID: 3035003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of anti-D immunoglobulin in the treatment of threatened miscarriage in the accident and emergency department.
    Weinberg L
    Emerg Med J; 2001 Nov; 18(6):444-7. PubMed ID: 11696491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-throughput non-invasive prenatal testing for fetal rhesus D status in RhD-negative women not known to be sensitised to the RhD antigen: a systematic review and economic evaluation.
    Saramago P; Yang H; Llewellyn A; Walker R; Harden M; Palmer S; Griffin S; Simmonds M
    Health Technol Assess; 2018 Mar; 22(13):1-172. PubMed ID: 29580376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin supplementation for preventing miscarriage.
    Rumbold A; Middleton P; Crowther CA
    Cochrane Database Syst Rev; 2005 Apr; (2):CD004073. PubMed ID: 15846697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.